Clinical trials
Completed Phase 2 Tuberous Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 2 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 1 |
| Longboard Pharmaceuticals | 1 |
| Marinus Pharmaceuticals | 1 |
| Martina Bebin | 1 |
| Mustafa Sahin | 1 |
| NYU Langone Health | 1 |
| Noema Pharma AG | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberous Sclerosis | 12 |
| Epilepsy | 3 |
| Autistic Disorder | 2 |
| Epilepsies, Myoclonic | 2 |
| Lennox Gastaut Syndrome | 2 |
| Seizures | 2 |
| Angiofibroma | 1 |
| Angiomyolipoma | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.